html { overflow: visible; height: auto; } .MainNav_ItemWrapper:hover .Subnavigation_Wrapper, .MainNav_Item:focus + .Subnavigation_Wrapper { display: block; } .Header-FixedHeight .Dialoog, .Header-FixedHeight .Title_Wrapper, .Accordion_ContentContainer.Hidden { height: auto !important; visibility: visible; } .Dialoog_Step.Invisible, .Title_Wrapper.Invisible, main.Invisible, .js-GridItem { transform: none; opacity: 1; } .Dialoog_Form, .js-OptionsOpenBtn, .Image_Wrapper-Scaled, .Video_Wrapper-Scaled, img[data-src] { display: none; } .js-MasonryGrid { display: flex; flex-wrap: wrap; }

FH - hereditary leiomyomatosis and renal cell cancer

This test is available for the following conditions:

Conditions > Renal / Nephrological > Leiomymatosis + kidney cancer
Conditions > Oncogenetics > Leiomymatosis + kidney cancer

This product is also part of the following panels:

Comprehensive preconception carrier test panel¹
Hereditary cancer panel
Intellectual disability panel with genome wide CNV analysis
Liver disorders panel
Mendelian inherited disorders panel with genome wide CNV analysis
Metabolic disorders panel
Mitochondrial disorders panel
panel hereditary renalcancer (SDHA, SDHB, SDHC, SDHD, SDHAF2, VHL, PTEN, FLCN, MET, FH, BAP1)
Skin disorders panel¹

Turnaround time
Complete analysis & Targeted analysis: 3 weeks

Method